Simplified Whole Body Plethysmography to Characterize Lung Function During Respiratory Melioidosis
February 24th, 2023
7.3K views
This protocol presents the construction and use of a Simplified Whole Body Plethysmography apparatus to monitor bacterial respiratory disease progression non-invasively.
Overview
This protocol presents the construction and use of a Simplified Whole Body Plethysmography apparatus to monitor bacterial respiratory disease progression non-invasively. This technique allows for the collection of respiratory data from non-restrained animals, providing insights into lung function and disease progression.
Key Study Components
Area of Science
- Neuroscience
- Respiratory physiology
- Animal research
Background
- Simplified Whole Body Plethysmography (SWBP) is used to assess respiratory function.
- The method is advantageous for studying disease progression in live animals.
- Environmental factors can affect respiratory measurements.
- Calibration and setup are crucial for accurate data collection.
Purpose of Study
- To monitor respiratory disease progression in mice.
- To evaluate the effects of anesthetics on breathing patterns.
- To assess breath volume as a potential biomarker for disease severity.
Methods Used
- Setup of the SWBP apparatus and calibration procedures.
- Recording of respiratory data during various conditions.
- Analysis of breath rate and volume during anesthesia recovery.
- Monitoring changes in breathing during bacterial infections.
Main Results
- Breath rate decreased significantly during the first day of infection.
- Breath volume showed a steady decline over the course of the disease.
- Recovery from anesthesia was characterized by increased breath rate.
- Data suggests breath volume may indicate respiratory disease severity.
Conclusions
- SWBP is effective for non-invasive monitoring of respiratory function.
- Breath volume can serve as a biomarker for disease severity.
- Anesthetic effects on breathing patterns are significant and measurable.
Frequently Asked Questions
What is Simplified Whole Body Plethysmography?
It is a technique used to measure respiratory function in live animals without restraint.
How does the SWBP apparatus work?
It monitors respiratory parameters by analyzing airflow in a controlled chamber.
What are the advantages of using SWBP?
It allows for non-invasive data collection and minimizes stress on the animals.
What factors can affect respiratory measurements?
Environmental temperature, humidity, and the subject's own body temperature can influence results.
How can breath volume indicate disease severity?
Changes in breath volume may correlate with the progression of respiratory diseases.
What role do anesthetics play in respiratory studies?
Anesthetics can alter breathing patterns, which are important to monitor during experiments.
Executive Industry Relevance
Non-invasive respiratory monitoring in disease models supports early detection of functional decline and informs humane endpoint criteria. Simplified Whole Body Plethysmography (sWBP) enables longitudinal assessment of lung function in unrestrained animals, reducing stress and improving data quality. This approach enhances predictive confidence in preclinical respiratory disease models by providing quantitative, translational readouts of disease severity.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses by linking lung function changes to disease progression in infectious disease models.
- Operational Value: Provides non-invasive, longitudinal respiratory data without animal restraint, supporting ethical study design.
- Predictive Value: Breath volume and rate measurements offer quantifiable biomarkers for assessing disease severity and treatment response.
Screening & Assay Development
- Scientific Value: Generates standardized, reproducible respiratory parameters (breath rate, volume, minute volume) for compound screening in respiratory disease models.
- Operational Value: sWBP setup allows rapid, high-throughput sampling with minimal technical variability after calibration.
- Assay Readiness: Enables preparation of validated biological systems for downstream evaluation of therapeutics targeting lung function.
Translational & Preclinical Research
- Translational Continuity: Breath volume decline correlates with respiratory melioidosis progression, supporting its use as a translational biomarker.
- Preclinical Modeling: Facilitates disease-relevant system refinement by monitoring functional outcomes across the disease course.
- Mechanistic De-risking: Helps distinguish between breath rate and volume dynamics to better understand pathophysiological mechanisms.
Pipeline & Workflow Integration
sWBP fits within the discovery continuum from early target validation through preclinical efficacy testing, particularly for respiratory pathogens and lung-targeted therapeutics.
- Discovery Biology: Supports hypothesis testing by measuring functional lung output in vivo during infection and treatment.
- Screening: Delivers quantitative, assay-ready respiratory metrics that enable reliable comparison across experimental groups.
- Analytics: Provides time-series data on breath rate and volume, enabling statistical analysis of disease progression and intervention effects.
- Translational Research: Connects functional respiratory changes to disease severity, supporting biomarker qualification efforts.
- Enterprise Reuse: The calibrated sWBP platform can be reused across multiple infectious disease and respiratory toxicity studies.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence by reducing mechanistic ambiguity in lung function assessment.
- Operational Value: Delivers standardized, reproducible respiratory measurements with low animal stress.
- Strategic Value: Improves go/no-go decisions through objective, longitudinal functional endpoints.
- Portfolio Impact: Enables risk-adjusted prioritization of compounds based on functional lung recovery data.
Implementation Considerations
- Requires expertise in physiological data acquisition and respiratory signal processing.
- Depends on stable instrumentation including bridge amplifiers, data acquisition systems, and analysis software.
- Necessitates cross-team standardization of calibration protocols (e.g., 20-microliter pulse validation) for reproducible results.
- Adaptation across model systems may require chamber size and flow rate adjustments based on subject size and breathing dynamics.
- Practical limitation: Subject movement artifacts must be minimized by ensuring animal stillness before recording initiation.
Biopharma FAQs
Why does breath rate measurement matter for target validation in respiratory infection models?
Breath rate provides a sensitive, early indicator of respiratory dysfunction during disease progression. In respiratory melioidosis, breath rate decreases rapidly within the first day of infection and remains low throughout the disease course. This change reflects host physiological response to lung infection and can be used to assess the impact of therapeutic interventions on lung function recovery.
How does isolation of the independent variable (e.g., infection status) support discovery pipeline decisions?
By monitoring breath parameters in infected versus control mice, researchers isolate the effect of respiratory melioidosis on lung function. This enables clear attribution of functional changes to the disease state rather than confounding factors. Such isolation supports target validation by confirming that observed respiratory deficits are disease-driven and thus amenable to therapeutic intervention.
What quantitative dependent variable measurements enable assessment of respiratory disease severity?
Breath volume and minute volume serve as quantitative dependent variables that track changes in lung function over time. In the study, breath volume showed a steady decline over the three-day disease course, offering a gradated measure of severity. These metrics allow researchers to correlate functional decline with bacterial load, host response, or treatment efficacy.
Why do replication requirements matter for cross-functional collaboration in respiratory phenotyping?
Replication across multiple recording sessions and subjects ensures data reliability and reduces variability due to animal handling or technical noise. In the protocol, measurements were repeated three times per subject to validate breath volume calculations. Consistent, replicable outputs enable confident data sharing between discovery, toxicology, and translational teams.
What statistical analysis capabilities are required before implementing sWBP in preclinical respiratory studies?
Implementation requires the ability to calculate average cyclic height and breath volume from plethysmography signals, then derive minute volume over time. Researchers must be able to export data to Excel or similar tools for group-level statistical comparison (e.g., t-tests, ANOVA) across infection stages or treatment groups. These capabilities are essential for determining significant changes in respiratory function and supporting go/no-go decisions.
